Clinical Trial Update: Safety and Immunogenicity of HIL-214 With Routine Pediatric Vaccines [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reporting safety and immunogenicity results for the pediatric gastroenteritis vaccine HIL-214 in Phase 2/3, evaluated with routine pediatr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteritis

Drugs mentioned

• HIL-214

Snippet

Sponsor: HilleVax | Conditions: Gastroenteritis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2025-03-12